Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

ITI Pharma and Healthcare Fund · Direct ✕HDFC Business Cycle Fund · Direct ✕

Growth of ₹10,000

Basics

ITI Pharma and Healthcare FundHDFC Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseITIHDFC
NAV₹20.7004₹16.4070
NAV date20 Nov 202620 Nov 2026
History5.0 years4.0 years
Expense ratio0.9%1.1%
Stars★★★★★★★★★★
Growth Score72.8050.50

Returns

ITI Pharma and Healthcare FundHDFC Business Cycle Fund
1 month+11.35%+7.69%
3 months+4.42%+1.91%
6 months+12.33%+11.83%
YTD+21.31%+7.72%
1 year+18.01%+5.98%
3 years (CAGR)+19.94%+12.01%
5 years (CAGR)+15.73%—
10 years (CAGR)——
Since launch+15.56%+13.24%

Risk

ITI Pharma and Healthcare FundHDFC Business Cycle Fund
Volatility15.9%15.5%
Downside volatility10.1%10.3%
Sharpe0.850.36
Sortino1.340.53
Calmar1.170.67
Return / risk1.250.78
Deepest fall−17.69%−18.04%
Days to recover364133
Below its high+0.00%+0.00%

Against benchmark

ITI Pharma and Healthcare FundHDFC Business Cycle Fund
Alpha−1.30%+0.41%
Beta0.980.92
R²84.6%90.6%
Up capture94.1%95.3%
Down capture98.8%92.0%
Tracking error6.2%4.9%
Information ratio−0.26−0.01
Treynor0.130.05

Consistency

ITI Pharma and Healthcare FundHDFC Business Cycle Fund
Best 1-year+61.91%+39.99%
Middle 1-year+15.57%+6.68%
Worst 1-year−9.32%−6.17%
1-year periods with a loss21.7%9.1%
Middle 3-year+21.36%+12.75%
Positive months72.2%61.1%
Best day+3.48%+4.12%
Worst day−3.28%−6.25%
Worst 5% day−1.48%−1.52%
Positive days56.0%54.9%
NAVs a year247247

SIP of ₹10,000 a month

ITI Pharma and Healthcare FundHDFC Business Cycle Fund
5-year XIRR——
5-year value——
3-year XIRR+15.60%+8.57%
1-year XIRR+27.81%+15.07%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth